Clinical Trial Update: Evaluation of Glistening, Visual Outcomes and General Safety 24 Months Post-IOL Implantation

View source ↗

Summary

This clinical trial update reports 24-month outcomes after intraocular lens implantation, focusing on glistening, visual outcomes, and overall safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Senile Cataract

Snippet

Sponsor: Carl Zeiss Meditec AG | Conditions: Cataract Senile | Status: COMPLETED